河合 秀樹

Medicine & Life Sciences

1. Computed Tomography Angiography 100%
2. Coronary Vessels 51%
3. Acute Coronary Syndrome 44%
4. Brain Natriuretic Peptide 42%
5. Tomography 42%
6. duramycin 40%
7. Coronary Artery Disease 36%
8. Pathologic Constriction 35%
9. Coronary Angiography 31%
10. fibrin fragment D 31%
11. Myocardial Perfusion Imaging 28%
12. Rivaroxaban 26%
13. Fatty Acid-Binding Proteins 26%
14. Stroke Volume 24%
15. Molecular Imaging 24%
16. Myocardial Infarction 23%
17. Atrial Fibrillation 23%
18. Sarcoidosis 22%
19. Optical Coherence Tomography 20%
20. Carotid Arteries 19%
21. Reperfusion Injury 19%
22. Echocardiography 19%
23. Stents 18%
24. Troponin I 18%
25. Annexin A5 18%
26. Intensive Care Units 16%
27. Heart Failure 16%
28. phosphatidylethanolamine 16%
29. Acute Kidney Injury 16%
30. Angioscopy 15%
31. Mortality 15%
32. HSP72 Heat-Shock Proteins 15%
33. Anomalous Left Coronary Artery 15%
34. Reperfusion 14%
35. technetium 99m HYNIC-duramycin 14%
36. Coronary Stenosis 13%
37. Spinocerebellar Ataxias 13%
38. Apoptosis 13%
39. Myocardial Ischemia 13%
40. Genetic Testing 13%
41. Warfarin 13%
42. Chronic Renal Insufficiency 12%
43. Mucocutaneous Lymph Node Syndrome 12%
44. Coronavirus 12%
45. Eicosapentaenoic Acid 12%
46. Coronary Sinus 12%
47. Troponin 12%
48. Carotid Endarterectomy 11%
49. Glomerular Filtration Rate 11%
50. Ischemia 11%